Advancing Neonatal Jaundice Screening with Clinical Evidence

At Picterus, we are committed to improving neonatal jaundice screening through rigorous clinical research, supported by peerreviewed evidence and realworld validation across diverse care pathways, including both clinical and home settings.

The current commercialised version of Picterus Jaundice Pro represents the most mature iteration of the technology and is supported by the most recent clinical evidence. This version is evaluated in the latest clinical studies (not yet peer reviewed), while additional ongoing and planned research explores future development approaches. A dedicated white paper summarises the performance of the current software generation based on the latest available data.  

Download our White Paper

In-depth insight into Picterus technology

Want to learn more about the science and validation behind Picterus Jaundice Pro? Download our latest white paper to explore the clinical background, methodology, and global relevance of our screening solution.

Understanding clinical evidence across software versions

Picterus Jaundice Pro has undergone multiple software generations since its initial clinical validation. Each generation represents a distinct version of the algorithm and user interface, reflecting ongoing development and improvements informed by clinical research and realworld use. 

 

The earliest version of Picterus Jaundice Pro, evaluated in initial clinical studies with data collection between 2017 – 2019, and corresponding publication in the year after: Aune, Anders et al. “Bilirubin estimates from smartphone images of newborn infants’ skin correlated highly to serum bilirubin levels.” Acta paediatrica (Oslo, Norway : 1992) vol. 109,12 (2020): 2532-2538. doi:10.1111/apa.15287 

This version relied on predefined analytical models informed by simulated skin characteristics and reference bilirubin values. The first generation of the app supported foundational feasibility and validation studies and established the clinical potential of smartphone based bilirubin screening. Details are described in the publication: Aune, Anders et al. “Iterative Development, Validation, and Certification of a Smartphone System to Assess Neonatal Jaundice: Development and Usability Study.” JMIR pediatrics and parenting vol. 6 e40463. 28 Feb. 2023, doi:10.2196/40463

Subsequent generations of the software introduced refinements to image analysis, calibration, and user experience, informed by additional clinical data, expanded use contexts, and feedback from healthcare professionals. This also included an updated version of the Picterus Calibration Card, with added colour swatches to open for a wider variety in colour interpretation  

Over time, the software evolved toward more data driven approaches, including the use of machine learning methods, enabling performance to be refined based on accumulated clinical experience. As earlier clinical datasets informed the development of newer software generations, they are not reused as independent validation cohorts. More recent clinical studies therefore focus on evaluating the performance of the current version of the app. 

When reviewing the clinical evidence, it is therefore important to consider the software version used in each study, as well as the intended use context at the time of evaluation. 

Explore our peer-reviewed publications below to learn more about the clinical validation behind Picterus.

2025

Validation of a Mobile Health Device for Neonatal Jaundice Screening: A Cross-Sectional Study in a Resource-Limited Setting in Mexico.

2025

Smartphone-based screening of neonatal jaundice in three populations in low and middle-income countries: a cross-sectional study.

2024

Neonatal jaundice detection in low-resource Mexican settings: possibilities and barriers for innovation with mobile health.

2023

Iterative Development, Validation, and Certification of a Smartphone System to Assess Neonatal Jaundice: Development and Usability Study.

2023

Healthcare workers’ perceptions about the use of mobile health technologies in public health facilities in Lagos, Nigeria.

2020

Bilirubin estimates from smartphone images of newborn infants’ skin correlated highly to serum bilirubin levels.

Research Pipeline

At Picterus, continuous improvement is guided by ongoing clinical research and realworld data. Our research pipeline focuses on the systematic evaluation and refinement of our technology across key areas:

Join our newsletter

I hereby confirm that *

Access our neonatal jaundice and Picterus Jaundice Pro e-learning course

This Course will equip you with the essential knowledge and practical skills to confidently assess and manage neonatal jaundice, using tools like Picterus® Jaundice Pro for accurate screening. You’ll also explore clinical guidelines and best practices to ensure that your decisions align with clinical recommendations.

The course is free! Sign up today!

I hereby confirm that *